How an Aussie study on transgender ‘desistance’ rates became a culture war flashpoint
A group of doctors at The Children’s Hospital at Westmead in Sydney made headlines last year following the publication of their research paper in an…
Kemal Atlay
Kemal is a reporter at Australian Doctor Group covering clinical and medicopolitical news.
‘We did not expect these results’: Testosterone therapy linked to higher fracture risk
Testosterone treatment may increase fracture risk in middle-aged and older men with hypogonadism, according to new research that contradicts conventional wisdom. While exogenous testosterone has…
‘Humble and warm-hearted GP’, who retired aged 92, dies
A GP who was Tasmania’s oldest working doctor when he retired in his 90s, has died at the age of 96, at the hospital where…
Medical Must-See: Man survives accidentally shooting nail into his eye
They say hindsight is 20/20 — perhaps a cruel maxim in the case of a construction worker who experienced a transorbital penetrating brain injury after…
Radiology college backs mandatory breast density reporting
All women undergoing routine mammography should be notified of their breast density, the peak body for radiologists says. In a new position statement published in…
Ultrasound ‘helmet’ disrupts blood-brain barrier in Alzheimer’s therapy
Temporarily disrupting the blood–brain barrier with a focused ultrasound helmet could boost the efficacy of monoclonal antibody treatments for early Alzheimer’s disease, research shows. MRI-guided…
Women missing out on HIV PrEP, doctors warn
Women are overlooked for HIV pre-exposure prophylaxis under Australian guidelines and risk being left behind in the race to eliminate HIV transmission, according to sexual…
FDA investigates secondary malignancy risk with CAR T-cell therapy
The TGA is closely watching an overseas investigation of chimeric antigen receptor T-cell therapies after reports of secondary malignancies in treated patients. Last month, the…
Bone density loss from puberty blockers ‘reversible’ in transgender patients
Bone density loss in teenagers with gender dysphoria prescribed puberty blockers is mostly reversible with long-term gender-affirming hormone treatment in adulthood, Dutch doctors report in a…
Semaglutide ‘shows promise’ for secondary CV prevention regardless of diabetes status
Adding semaglutide to standard care cuts the risk of fatal and non-fatal cardiac events by 20% in adults with pre-existing cardiovascular disease but not diabetes,…
